Ton, NC; Parker, GJ; Jackson, A; Mullamitha, S; Buonaccorsi, GA; Roberts, C Phase I evaluation of CDP791, a PEGylated di-Fab' conjugate that binds vascular endothelial growth factor receptor 2. Clinical cancer research: An official journal of the American Association for Cancer Research., 2007, 13, 7113-8.
Hirsch, FR; McElhinny, A; Stanforth, D; Ranger-Moore, J; Jansson, M; Kulangara, K PD-L1 Immunohistochemistry Assays for Lung Cancer: Results from Phase 1 of the Blueprint PD-L1 IHC Assay Comparison Project Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 2017, 12, 208-22.
Hendry, S; Byrne, DJ; Wright, GM; Young, RJ; Sturrock, S Cooper, WA Comparison of Four PD-L1 Immunohistochemical Assays in Lung Cancer. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2018, 13, 367-76.
Fujimoto, D; Sato, Y; Uehara, K; Ishida, K; Fukuoka, J Morimoto, T Predictive Performance of Four Programmed Cell Death Ligand 1 Assay Systems on Nivolumab Response in Previously Treated Patients with Non-Small Cell Lung Cancer Journal of thoracic oncology: Official publication of the International Association for the Study of Lung Cancer 2018, 13, 377-86.